GenesisCare UK Strengthens Board with Appointment of Two Non-Executive Directors

GenesisCare UK, the UK’s leading private cancer care provider, is pleased to confirm the appointment of two Non-Executive Directors to its UK Board.

The newly appointed Non-Executive Directors are:

Stephen Collier, Chair of HCRG Care Group, a national community services provider, will take up the role of Non-Executive Director and Chair of its Quality Assurance Committee. Stephen is highly respected within the UK healthcare sector having Chaired the Health Purchasing Alliance, a joint venture between Aviva and Vitality Health, been the Senior Independent Director and Chair of the Workforce Committee at St. George’s University Hospitals NHS Foundation Trust and formerly Chief Executive Officer of BMI Healthcare, the largest private hospital provider in the UK between 2011 and 2014.

David Young, formerly Global CEO at GenesisCare, who led the global restructuring of the business between 2023 and 2024, will become a Non-Executive Director and Chair of its Remuneration and People Committee. Before joining GenesisCare, David had a highly successful career as President and CEO of PE GI Solutions, Chief Operating Officer at Privia Health Inc, and in leadership roles at US Oncology and McKesson Specialty Health.

Each of these individuals possesses a unique set of skills and experiences that will complement the existing board and contribute to the strategic growth and development of GenesisCare UK.

"I am delighted to welcome Stephen and David to GenesisCare UK" said Justin Hely, GenesisCare’s CEO of UK & Europe. "Their combined strategic and sector-based experience will be invaluable as we continue to focus on growing our network and delivering the highest possible standards of care to patients with a suspected or confirmed cancer diagnosis. I am very much looking forward to working with them.”

Stephen and David join GenesisCare UK at an exciting time of innovation and growth for the organisation, with plans to grow both the range of services provided to patients with cancer and the geographies in which they operate.

For more information about GenesisCare UK and its comprehensive cancer care services, please visit www.genesiscare.com/uk

About GenesisCare UK:

GenesisCare UK is the UK’s leading cancer care provider, transforming cancer care with advanced diagnostics, medical oncology, radiotherapy and Theranostics. Operating 14 specialist outpatient centres, we provide patients with a world-class standard of care, and access to the latest innovative treatments proven to be safe and effective, delivered by highly trained physicians and healthcare professionals. With a philosophy to treat the whole patient not just the cancer, we take an integrated cancer care approach. Our personalised treatment programmes are supported with wellbeing services delivered through our unique partnership with the charity Penny Brohn UK. We also provide exercise medicine, which is proven to deliver improved patient outcomes. In addition, we work with universities and leading clinicians around the world, to research and design new and better ways to treat cancers and have a growing UK clinical trials programme to support bringing new therapies to more patients. Treatments are available for patients with health insurance and those paying for their own care.

www.genesiscare.com/uk